Skip to content

Phytochemistry

ISSN 1873-3700

3 papers in the library · 98 citations · publishing 2007-2024

Papers

Sort Most recent Most cited

Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans.

Phytochemistry February 1, 2024 Rubi Barman, Pranjit Kumar Bora, Jadumoni Saikia et al. 9 citations

The family Myristicaceae harbour mind-altering phenylpropanoids like myristicin, elemicin, safrole, tryptamine derivatives such as N,N-dimethyltryptamine (DMT) and 5-methoxy N,N-dimethyltryptamine (5-MeO-DMT) and β-carbolines such as 1-methyl-6-methoxy-dihydro-β-carboline and 2-methyl-6-methoxy-1,2,3,4-tetrahydro-β-carboline. This study aimed to systematically review and propose the...

A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.

Phytochemistry May 1, 2017 André Cruz, Sara Domingos, Eugenia Gallardo et al. 44 citations

Until the mid-60s, only the Mazatecs, an indigenous group from Oaxaca, Mexico, used Salvia Divinorum (S. divinorum) due to its hallucinogen properties. Later it was found that the hallucinogen effects of this plant were caused by the presence of a neoclerodane diterpene Salvinorin A (salvinorin A), which is a highly selective agonist of kappa-opioid receptor (KOR) that cause more intense...

Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway.

Phytochemistry July 1, 2007 Lukasz Kutrzeba, Franck E Dayan, J'Lynn Howell et al. 45 citations

Salvinorin A, a neoclerodane diterpenoid, isolated from the Mexican hallucinogenic plant Salvia divinorum, is a potent kappa-opioid receptor agonist. Its biosynthetic route was studied by NMR and HR-ESI-MS analysis of the products of the incorporation of [1-(13)C]-glucose, [Me-(13)C]-methionine, and [1-(13)C;3,4-(2)H2]-1-deoxy-D-xylulose into its structure. While the use of cuttings and...